GPT and metabolic dysfunction-associated steatohepatitis: At-risk NASH patients had higher mean AST (65 vs. 40 U/L), ALT (78 vs. 58 U/L), LSM (15.2 vs. 9.3 kPa), and CAP scores (327 vs. 317 dB/m) and lower platelet counts (227K vs. 243K cells/μL).